Abstract
Enucleation as standard treatment for choroidal melanoma has been questioned because of the loss of sight on that side and the nearly 50% death rate at 5 years due to metastases (Reese 1963). Conservative treatment methods such as electrodiathermy (Weve 1960), photocoagulation (Meyer-Schwickerath 1961a,b; Vogel 1972a,b), irradiation (Stallard 1961, 1966), and microsurgical excision have been used with some success, destroying the tumor and preserving vision.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Augsburger II, Gamel IW, Sardi VF, Greenberg RA, Shields JA, Brady LW (1986) Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 104:655–661
Bedford MA, Bedotto C, MacFaul P (1970) Radiation retinopathy after the application of a cobalt plaque. Br J Ophthalmol 54:505–509
Catsch A (1968) Dekorporierung radioaktiver und stabiler Metallionen. Karl Thiemig, Munich
Char DH, Castro JR, Quivey JM et al. (1980) Helium ion charged particle therapy for choroidal melanoma. Ophthalmology 87:565–570
Cibis PA, Noell WK, Eichel B (1955) Ocular effects produced by high-intensity x-radiation. Arch Ophthalmol 53:651–663
Fine SL (1986) Do I take the eye out or leave it in? Arch Ophthalmol 104:653–654
Fossati F (1964) Die Behandlung von Retinoblastomen und Melanoblastomen der Uvea mit Implantation radioaktiver Kobaltdrähte. Strahlentherapie 124:180–197
Freundlich HF (1949) A new beta-ray applicator using fission products. Nature 164:308
Gragoudas ES, Goitein M, Verhey L et al. (1980) Proton beam irradiation: an alternative to enucleation for intraocular melanomas. Ophthalmology 87:571–581
Harmer MH, Oosterhuis JA (1985) TNM classification of ophthalmic tumors. UICC, Geneva
Hayreh SS (1970) Post-radiation retinopathy. A fluorescence fundus angiographic study. Br J Ophthalmol 54:705–714
Hegewald H, Lommatzsch P (1965) Strahlenschutz probleme bei der Anwendung radioaktiver Nuklide in der Ophthalmologie. Klin Monatsbl Augenheilkd 146:76–86
Jones CH, Dermentzoglou F (1971) Practical aspects of 90Sr ophthalmic applicator dosimetry. Br J Radiol 44:203–210
Kahn HA (1983) An introduction to epidemiologic methods. Oxford University Press, New York
Kastner J, Hukkoo Ramesh, Oltman BG, Dajal Y (1967) Thermoluminescent internal beta ray dosimetry. Radiat Res 32:625–640
Kiehl H, Kirsch I, Lommatzsch P (1984) Das Überleben nach Behandlung des malignen Melanoms der Aderhaut: Vergleich von konservativer Therapie (Ru-106/Rh-106 Applikator) und Enukleation ohne und mit postoperativer Orbitabestrahlung. Klin Monatsbl Augenheilkd 184:2–14
Kunz W, Schintlmeister J (1958) Tabelle der Atomkerne. CM Hollander, Berlin
Lederer CM, Hollander JM, Pearlman J (1967) Table of isotopes, 6th edn. Wiley & Sons, New York
Lederman M (1961) Radiotherapy of malignant melanoma of the eye. Br J Radiol 34:21–42
Lommatzsch P (1970) Die Anwendung von Betastrahlen mit Ru-106/Rh-106 Applikatoren bei der Behandlung des Retinoblastoms. Klin Monatsbl Augenheilkd 156:662–669
Lommatzsch P (1974) Treatment of choroidal melanomas with Ru-106/Rh-106 applicators. Surv Ophthalmol 19:85–100
Lommatzsch P, Vollmar R (1959) Recommendations of the International Commission on Radiological Protection. ICRP Publ 2, Report of Committee II on Permissible Dose for Internal Radiation. Pergamon, London
Lommatzsch P, Vollmar R (1964) Einige Ergebnisse der Beta-Therapie bei epibulbären Tumoren. Klin Monatsbl Augenheilkd 144:856–871
Lommatzsch P, Vollmar R (1966) Ein neuer Weg zur konservativen Therapie intraokularer Tumoren mit Betastrahlen (Ruthenium-106) unter Erhaltung der Sehfähigkeit. Klin Monatsbl Augenheilkd 148:682–699
MacFaul PA, Bedford MA (1970) Ocular complications after therapeutic irradiation. Br J Ophthalmol 54:237–247
Magnus L (1967) Tiefendosisberechnung für die Co-60-Augenapplikatoren CKA 1–4 (nach Stallard). Strahlentherapie 132:379–386
Magnus L, Göbbeler T, Strötges W (1968) Tiefendosisberechnung für Co-60-Augenapplikatoren CKA 5–11 (nach Stallard). Strahlentherapie 136:170–177
Meyer-Schwickerath G (1961a) Die Möglichkeiten zur Behandlung intraokularer Tumoren unter Erhaltung des Sehvermögens. Ber Dtsch Ophthalmol Ges 63:178–189
Meyer-Schwickerath G (1961b) The preservation of vision by treatment of intraocular tumors with light coagulation. Arch Ophthalmol 66:458–466
Moore RF (1930) Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 14:145–152
Nachtigall D (1969) Table of specific gamma ray contents. Thiemig, Munich
Packer S, Rotman M, Fairchild RG et al. (1980) Irradiation of choroidal melanoma with iodine 125 ophthalmic plaque. Arch Ophthalmol 98:1453–1457
Reese AB (1963) Tumors of the eye, 2nd edn. Hoeber, New York, p 232
Rosengren BHO, Tengroth B (1963) A modified cobalt 60 applicator for the treatment of retinoblastoma. Acta Radiol 1:305–313
Schmidt H (1978) Betadosimetrie von Augen-Applikatoren. Der Augenarzt Band V, Ed. Karl Velhagen, VEB Georg Thieme Leipzig, 356–357
Seddon JM, Gragoudas ES, Albert DM et al. (1985) Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 99:282–290
Stallard HB (1961) Malignant melanoma of the choroid treated with radioactive applicators. Ann Roy Coll Surg England 29:170–182
Stallard HB (1966) Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 50:147–155
Thompson RC, Weeks MH, Hollis OL, Ballon JE, Oakley WD (1958) Metabolism of radio-ruthenium in the rat. Consideration of permissible exposure limits. Am J Roentgenol Radium Ther Nucl Med 79:1026–1044
Tochilin E, Golden R (1953) Film measurement of beta-ray depth dose. Nucleonics 11/8:26–29
Vogel MH (1972a) Treatment of malignant choroidal melanomas with photocoagulation. Evaluation of 10 year follow-up data. Am J Ophthalmol 74:1
Vogel MH (1972b) Histopathologic observations of photocoagulated malignant melanomas of the choroid. Am J Ophthalmol 74:466–474
Vollmar R, Lommatzsch P, Hegewald H (1964) Vorteile der Betatherapie in der ophthalmologischen Radiologie. Radiobiol Radiother 5:575–583
Weve HJ (1960) Die Möglichkeiten zur Behandlung intraokularer Tumoren unter Erhaltung des Sehvermögens. Ber Dtsch Ophthalmol Ges 63:167–178
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lommatzsch, P.K. (1993). Treatment of Choroidal Melanomas with 106Ru/106Rh Beta Ray Applications. In: Alberti, W.E., Sagerman, R.H. (eds) Radiotherapy of Intraocular and Orbital Tumors. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97011-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-97011-5_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97013-9
Online ISBN: 978-3-642-97011-5
eBook Packages: Springer Book Archive